Assessing the Benefit of Art & Music Therapy on Quality of Life in Patients With Breast Cancer
A Randomized Controlled Trial to Assess the Benefit of Art & Music Therapy on Quality of Life in Patients With Breast Cancer
1 other identifier
interventional
73
1 country
1
Brief Summary
This is a study of art-based and music-based therapy programs lasting three months (with additional follow-up 3 months after the end of the trial) in breast cancer patients currently receiving therapy as well as in cancer survivors.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable breast-cancer
Started Apr 2021
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
July 27, 2020
CompletedFirst Posted
Study publicly available on registry
July 30, 2020
CompletedStudy Start
First participant enrolled
April 21, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 22, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
January 22, 2024
CompletedDecember 18, 2024
December 1, 2024
2.8 years
July 27, 2020
December 17, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (4)
Functional Assessment of Cancer Therapy: Breast Cancer (FACT-B) questionnaire scores
Quality of life (QOL) as measured by Functional Assessment of Cancer Therapy: Breast Cancer (FACT-B) questionnaire. This is a validated survey, completed by the patient, consisting of 37 items, each scored on a 0-4, Likert scale (0 = "Not at all"; 4= "Very much"). Subscales include: Physical Well-Being (PWB) (score range: 0-28), Social/Family Well-Being (SWB) (score range: 0-28), Emotional Well-Being (EWB) (score range: 0-24), Functional Well-being (FWB) (score range: 0-28), and the additional breast cancer concerns (BCS) (score range: 0-40) all with higher scores indicating better outcomes. Total scale scores range from 0 to 148 with higher scores indicating better outcomes.
Baseline
FACT-B questionnaire scores
QOL as measured by FACT-B questionnaire scores. This is a validated survey, completed by the patient, consisting of 37 questions, each scored on a 0-4, Likert scale (0 = "Not at all"; 4= "Very much"). Subscales include: PWB (score range: 0-28), SWB (score range: 0-28), EWB (score range: 0-24), FWB (score range: 0-28), and BCS (score range: 0-40) all with higher scores indicating better outcomes. Total scale scores range from 0 to 148 with higher scores indicating better outcomes.
At 30-days
FACT-B questionnaire scores
QOL as measured by FACT-B questionnaire scores. This is a validated survey, completed by the patient, consisting of 37 questions, each scored on a 0-4, Likert scale (0 = "Not at all"; 4= "Very much"). Subscales include: PWB (score range: 0-28), SWB (score range: 0-28), EWB (score range: 0-24), FWB (score range: 0-28), and BCS (score range: 0-40) all with higher scores indicating better outcomes. Total scale scores range from 0 to 148 with higher scores indicating better outcomes.
At 90-days
FACT-B questionnaire scores
QOL as measured by FACT-B questionnaire scores. This is a validated survey, completed by the patient, consisting of 37 questions, each scored on a 0-4, Likert scale (0 = "Not at all"; 4= "Very much"). Subscales include: PWB (score range: 0-28), SWB (score range: 0-28), EWB (score range: 0-24), FWB (score range: 0-28), and BCS (score range: 0-40) all with higher scores indicating better outcomes. Total scale scores range from 0 to 148 with higher scores indicating better outcomes.
At 180-days
Secondary Outcomes (16)
Functional Assessment of Cancer Therapy - Cognition (FACT-Cog) questionnaire scores
Baseline
FACT-Cog questionnaire scores
At 30-days
FACT-Cog questionnaire scores
At 90-days
FACT-Cog questionnaire scores
At 180-days
Generalized Anxiety Disorder-7 item (GAD-7) scores
Baseline
- +11 more secondary outcomes
Study Arms (3)
Art Therapy
EXPERIMENTALWeekly sessions, alternating: in-person sessions (6 over 3 months), home assignments (6 over 3 months)
Music Therapy
EXPERIMENTALWeekly sessions, alternating: in-person sessions (6 over 3 months), home assignments (6 over 3 months)
Standard Of Care
NO INTERVENTIONA list of support services is provided. No requirement to attend sessions and no home assignments
Interventions
The art therapist will assist each participant in producing a bound collection of participant art works/writings for personal, group and/or caregiver inspiration, at the participant's request. For in-person sessions, a variety of studio-based art and writing materials will be available for participant selection and creation. Each session will be directed in the following manner: * New therapeutic prompt or bridge from prior session * Creative expression, opportunity for reflection, verbal sharing / processing, and a session summary * Discussion of action plan for the next consecutive, at-home session (weekly assignment). Possible wellness themes for each session (in-person or at-home) may include: mental health, physical health, emotional health, spiritual health, relational health (family and social), or occupational health/financial health.
Participants have the opportunity to engage in: learning an instrument, active music-making, receptive music-listening, singing, improvisation, song-writing, education on music technology, or music discussion. During in-person musical sessions the six psychosocial goals promoted by the music therapist include: 1) self-care/self-love, 2) support systems, 3) practicing positivity 4) gratitude 5) mindfulness/living in the moment, and 6) goal-setting. For at-home assignments, participants will be asked to pick a song of the week that coincides with the theme/goal discussed in previous session(s). They will be asked to write a journal entry about the topic discussed. Journal entries can be freely written or a prompt/question can be provided. If participants do not have access to search for songs or listen to music as at home, they may select a piece from the session and be given lyrics and/or a recording on an .mp3 player returned at conclusion of study.
Eligibility Criteria
You may qualify if:
- Breast cancer diagnosis (stage 0-III)
- Treated at Cleveland Clinic by medical oncologist, radiation oncologist, and/or breast surgeon Patients currently undergoing treatment or have completed active treatment (surgery, radiation or chemotherapy) within past 5 years.
- Able and willing to participate in art or music therapy programs at Maroone Cancer Center
- Subjects must have the ability to understand and the willingness to sign a written informed consent document
- Ability to read and write in English
- Performance status 0 or 1 as per ECOG scale
You may not qualify if:
- No prior history of breast cancer
- History of metastatic disease (Stage IV)
- Not being followed by medical oncologist, radiation oncologist, and/or breast surgeon at Cleveland Clinic
- Unable or unwilling to participate in art or music therapy program at Maroone Cancer Center
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Cleveland Clinic Florida Weston, Case Comprehensive Cancer Center
Weston, Florida, 33331, United States
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Zeina Nahleh, MD
Cleveland Clinic, Case Comprehensive Cancer Center
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
July 27, 2020
First Posted
July 30, 2020
Study Start
April 21, 2021
Primary Completion
January 22, 2024
Study Completion
January 22, 2024
Last Updated
December 18, 2024
Record last verified: 2024-12
Data Sharing
- IPD Sharing
- Will share
Will share manuscripts, presentations, and abstracts